PROPANC BIOPHARMA, INC. Basic Shares Outstanding (Weighted Average)
PROPANC BIOPHARMA, INC. (PPCB) reported Basic Shares Outstanding (Weighted Average) of 897.10 thousand shares for the 3-month period ending 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-17
- PROPANC BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 897.10K shares, a 418.43% increase year-over-year.
- PROPANC BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 13.36M shares, a 100000.08% increase year-over-year.
- PROPANC BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 12.33M shares, a 125105.87% increase year-over-year.
- PROPANC BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 464.47K shares.
- PROPANC BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.74M shares, a 2448.85% increase from fiscal 2022.
- PROPANC BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 68.22K shares, a 97.75% decline from fiscal 2021.
- PROPANC BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 3.03M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 897.10K shares S-1 · filed 2026-07-17 | 22.43M shares 10-Q · filed 2026-05-14 | 7.13M shares derived: average of 2 quarters · filed 2026-07-17 | 638.94K shares S-1 · filed 2026-07-17 | 15.97M shares 10-Q · filed 2026-05-14 | 6.76M shares derived: average of 4 quarters · filed 2026-07-17 | ||
| 2025-12-31 | 13.36M shares S-1 · filed 2026-04-10 | 12.85M shares S-1 · filed 2026-04-10 | 8.72M shares derived: average of 3 quarters · filed 2026-07-17 | 6.58M shares derived: average of 4 quarters · filed 2026-07-17 | ||||
| 2025-09-30 | 12.33M shares 10-Q · filed 2025-11-14 | 6.40M shares derived: average of 2 quarters · filed 2026-07-17 | 4.32M shares derived: average of 3 quarters · filed 2026-07-17 | 3.25M shares derived: average of 4 quarters · filed 2026-07-17 | ||||
| 2025-06-30 | 464.47K shares derived: S-1 12 month − S-1 9 month · filed 2026-07-17 | 318.76K shares derived: average of 2 quarters · filed 2026-07-17 | 216.95K shares derived: average of 3 quarters · filed 2026-07-17 | 158.73K shares S-1 · filed 2026-07-17 | 3.97M shares 10-K · filed 2025-09-29 | |||
| 2025-03-31 | 173.04K shares S-1 · filed 2026-07-17 | 4.33M shares 10-Q · filed 2025-05-15 | 93.19K shares derived: average of 2 quarters · filed 2026-07-17 | 56.81K shares S-1 · filed 2026-07-17 | 1.42M shares 10-Q · filed 2025-05-15 | 48.72K shares derived: average of 4 quarters · filed 2026-07-17 | ||
| 2024-12-31 | 13.35K shares S-1 · filed 2026-04-10 | 11.60K shares S-1 · filed 2026-04-10 | 7.29K shares derived: average of 3 quarters · filed 2026-07-17 | 5.71K shares derived: average of 4 quarters · filed 2026-07-17 | ||||
| 2024-09-30 | 9.85K shares 10-Q · filed 2025-11-14 | 590.94M shares 10-Q · filed 2024-11-14 | 4.25K shares derived: average of 2 quarters · filed 2026-07-17 | 3.17K shares derived: average of 3 quarters · filed 2026-07-17 | 2.47K shares derived: average of 4 quarters · filed 2026-07-17 | |||
| 2024-06-30 | -1.34K shares derived: S-1 12 month − 10-Q 9 month · filed 2026-07-17 | -173.50 shares derived: average of 2 quarters · filed 2026-07-17 | 16.67 shares derived: average of 3 quarters · filed 2026-07-17 | 57.00 shares S-1 · filed 2026-07-17 | 85.05M shares 10-K · filed 2024-09-30 | |||
| 2024-03-31 | 994.00 shares 10-Q · filed 2025-05-15 | 59.64M shares 10-Q · filed 2024-05-15 | 695.50 shares derived: average of 2 quarters · filed 2025-05-15 | 523.00 shares 10-Q · filed 2025-05-15 | 31.38M shares 10-Q · filed 2024-05-15 | 3.65M shares derived: average of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | 397.00 shares 10-Q · filed 2025-02-14 | 23.81M shares 10-Q · filed 2024-02-20 | 290.00 shares 10-Q · filed 2025-02-14 | 17.40M shares 10-Q · filed 2024-02-20 | 4.87M shares derived: average of 3 quarters · filed 2025-02-14 | 4.13M shares derived: average of 4 quarters · filed 2025-02-14 | ||
| 2023-09-30 | 10.99M shares 10-Q · filed 2024-11-14 | 7.30M shares derived: average of 2 quarters · filed 2024-11-14 | 5.51M shares derived: average of 3 quarters · filed 2024-11-14 | 4.37M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 3.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | 2.77M shares derived: average of 2 quarters · filed 2024-09-30 | 2.16M shares derived: average of 3 quarters · filed 2024-09-30 | 1.74M shares 10-K · filed 2024-09-30 | ||||
| 2023-03-31 | 1.92M shares 10-Q · filed 2024-05-15 | 1.92B shares 10-Q · filed 2023-05-15 | 1.44M shares derived: average of 2 quarters · filed 2024-05-15 | 1.12M shares 10-Q · filed 2024-05-15 | 1.12B shares 10-Q · filed 2023-05-15 | -34.76M shares derived: average of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | 960.47K shares 10-Q · filed 2024-02-20 | 960.47M shares 10-Q · filed 2023-02-10 | 718.36K shares 10-Q · filed 2024-02-20 | 718.36M shares 10-Q · filed 2023-02-10 | -46.99M shares derived: average of 3 quarters · filed 2024-02-20 | -18.66M shares derived: average of 4 quarters · filed 2024-02-20 | ||
| 2022-09-30 | 473.59K shares 10-Q · filed 2023-11-14 | 473.59M shares 10-Q · filed 2022-11-14 | -70.97M shares derived: average of 2 quarters · filed 2023-11-14 | -25.19M shares derived: average of 3 quarters · filed 2023-11-14 | -6.55M shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -142.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | -38.03M shares derived: average of 2 quarters · filed 2023-09-28 | -8.89M shares derived: average of 3 quarters · filed 2023-09-28 | 68.22K shares 10-K · filed 2023-09-28 | 68.22M shares 10-K · filed 2022-09-28 | |||
| 2022-03-31 | 66.35M shares 10-Q · filed 2023-05-15 | 57.86M shares derived: average of 2 quarters · filed 2023-05-15 | 47.56M shares 10-Q · filed 2023-05-15 | 37.53M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 49.37M shares 10-Q · filed 2023-02-10 | 38.32M shares 10-Q · filed 2023-02-10 | 27.92M shares derived: average of 3 quarters · filed 2023-02-10 | 21.80M shares derived: average of 4 quarters · filed 2023-02-10 | ||||
| 2021-09-30 | 27.14M shares 10-Q · filed 2022-11-14 | 17.19M shares derived: average of 2 quarters · filed 2022-11-14 | 12.61M shares derived: average of 3 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | 7.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-28 | 5.34M shares derived: average of 2 quarters · filed 2022-09-28 | 3.03M shares 10-K · filed 2022-09-28 | |||||
| 2021-03-31 | 3.45M shares 10-Q · filed 2022-05-16 | 1.63M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |